Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome-Reference-Cited by-同舟云学术

Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome

Published:2015-02-10 Issue:4 Volume:95 Page:325-330
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Cai Qian-Qian¹,Wang Chen¹,Cao Xin-Xin¹,Cai Hao¹,Zhou Dao-Bin¹,Li Jian¹

Affiliation:

1. Department of Hematology; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China

Funder

Beijing Natural Science Foundation

Specialized Research Fund for the Doctoral Program of Higher Education

Capital Health Research and Development of Special Fund

Peking Union Medical College New Star

National Public Health Grand Research Foundation

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12492/fullpdf

Reference18 articles.

1. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management;Dispenzieri;Am J Hematol,2014

2. New advances in the diagnosis and treatment of POEMS syndrome;Li;Br J Haematol,2013

3. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience;D'Souza;Blood,2012

4. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome;Li;Blood,2011

5. Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America;Weber;N Engl J Med,2007

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of bortezomib, cyclophosphamide, and dexamethasone for newly diagnosed POEMS syndrome patients;Therapeutic Advances in Neurological Disorders;2024-01

2. Daratumumab-RD InductionSequential Autologous Stem Cell Transplantation for a new diagnosed case of POEMS Syndrome with 17p deletion solitary plasmacytoma of bone;2023-12-21

3. Treatment and outcome of second-line therapy for POEMS syndrome after autologous stem cell transplantation;Bone Marrow Transplantation;2023-07-24

4. Daratumumab, Carfilzomib, Pomalidomide and Elotuzumab for the Treatment of POEMS Syndrome- The Mayo Clinic Experience;2022-12-19

5. Recent Advances in the Treatment and Supportive Care of POEMS Syndrome;Journal of Clinical Medicine;2022-11-27